dsRNA Viruses

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA

C12N2720/00dsRNA Viruses

C12N2720/00011dsRNA Viruses C12N2720/00021Viruses as such C12N2720/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/00023Virus like particles [VLP] C12N2720/00031Uses of virus other than therapeutic or vaccine C12N2720/00032Use of virus as therapeutic agent, other than vaccine C12N2720/00033Use of viral protein as therapeutic agent other than vaccine C12N2720/00034Use of virus or viral component as vaccine C12N2720/00041Use of virus, viral particle or viral elements as a vector C12N2720/00042virus or viral particle as vehicle C12N2720/00043viral genome or elements thereof as genetic vector C12N2720/00044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/00045Special targeting system for viral vectors C12N2720/00051Methods of production or purification of viral material C12N2720/00052relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/00061Methods of inactivation or attenuation C12N2720/00062by genetic engineering C12N2720/00063by chemical treatment C12N2720/00064by serial passage C12N2720/00071Demonstrated in vivo effect C12N2720/00088For redistribution C12N2720/10011Birnaviridae C12N2720/10021Viruses as such C12N2720/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/10023Virus like particles [VLP] C12N2720/10031Uses of virus other than therapeutic or vaccine C12N2720/10032Use of virus as therapeutic agent, other than vaccine C12N2720/10033Use of viral protein as therapeutic agent other than vaccine C12N2720/10034Use of virus or viral component as vaccine C12N2720/10041Use of virus, viral particle or viral elements as a vectorn C12N2720/10042virus or viral particle as vehicle C12N2720/10043viral genome or elements thereof as genetic vector C12N2720/10044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/10045Special targeting system for viral vectors C12N2720/10051Methods of production or purification of viral material C12N2720/10052relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/10061Methods of inactivation or attenuation C12N2720/10062by genetic engineering C12N2720/10063by chemical treatment C12N2720/10064by serial passage C12N2720/10071Demonstrated in vivo effect C12N2720/10088For redistribution C12N2720/12011Reoviridae C12N2720/12021Viruses as such C12N2720/12022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/12023Virus like particles [VLP] C12N2720/12031Uses of virus other than therapeutic or vaccine C12N2720/12032Use of virus as therapeutic agent, other than vaccine C12N2720/12033Use of viral protein as therapeutic agent other than vaccine C12N2720/12034Use of virus or viral component as vaccine C12N2720/12041Use of virus, viral particle or viral elements as a vector C12N2720/12042virus or viral particle as vehicle C12N2720/12043viral genome or elements thereof as genetic vector C12N2720/12044Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/12045Special targeting system for viral vectors C12N2720/12051Methods of production or purification of viral material C12N2720/12052relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/12061Methods of inactivation or attenuation C12N2720/12062by genetic engineering C12N2720/12063by chemical treatment C12N2720/12064by serial passage C12N2720/12071Demonstrated in vivo effect C12N2720/12088For redistribution C12N2720/12111Orbivirus C12N2720/12121Viruses as such C12N2720/12122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/12123Virus like particles [VLP] C12N2720/12131Uses of virus other than therapeutic or vaccine C12N2720/12132Use of virus as therapeutic agent, other than vaccine C12N2720/12133Use of viral protein as therapeutic agent other than vaccine C12N2720/12134Use of virus or viral component as vaccine C12N2720/12141Use of virus, viral particle or viral elements as a vectorn C12N2720/12142virus or viral particle as vehicle C12N2720/12143viral genome or elements thereof as genetic vector C12N2720/12144Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/12145Special targeting system for viral vectors C12N2720/12151Methods of production or purification of viral material C12N2720/12152relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/12161Methods of inactivation or attenuation C12N2720/12162by genetic engineering C12N2720/12163by chemical treatment C12N2720/12164by serial passage C12N2720/12171Demonstrated in vivo effect C12N2720/12188For redistribution C12N2720/12211Orthoreovirus C12N2720/12221Viruses as such C12N2720/12222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/12223Virus like particles [VLP] C12N2720/12231Uses of virus other than therapeutic or vaccine C12N2720/12232Use of virus as therapeutic agent, other than vaccine C12N2720/12233Use of viral protein as therapeutic agent other than vaccine C12N2720/12234Use of virus or viral component as vaccine C12N2720/12241Use of virus, viral particle or viral elements as a vector C12N2720/12242virus or viral particle as vehicle C12N2720/12243viral genome or elements thereof as genetic vector C12N2720/12244Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/12245Special targeting system for viral vectors C12N2720/12251Methods of production or purification of viral material C12N2720/12252relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/12261Methods of inactivation or attenuation C12N2720/12262by genetic engineering C12N2720/12263by chemical treatment C12N2720/12264by serial passage C12N2720/12271Demonstrated in vivo effect C12N2720/12288For redistribution C12N2720/12311Rotavirus C12N2720/12321Viruses as such C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes C12N2720/12323Virus like particles [VLP] C12N2720/12331Uses of virus other than therapeutic or vaccine C12N2720/12332Use of virus as therapeutic agent, other than vaccine C12N2720/12333Use of viral protein as therapeutic agent other than vaccine C12N2720/12334Use of virus or viral component as vaccine C12N2720/12341Use of virus, viral particle or viral elements as a vector C12N2720/12342virus or viral particle as vehicle C12N2720/12343viral genome or elements thereof as genetic vector C12N2720/12344Chimeric viral vector comprising heterologous viral elements for production of another viral vector C12N2720/12345Special targeting system for viral vectors C12N2720/12351Methods of production or purification of viral material C12N2720/12352relating to complementing cells and packaging systems for producing virus or viral particles C12N2720/12361Methods of inactivation or attenuation C12N2720/12362by genetic engineering C12N2720/12363by chemical treatment C12N2720/12364by serial passage C12N2720/12371Demonstrated in vivo effect C12N2720/12388For redistribution